Suchergebnisse - "Goel, Gautam"

PubPharm (8)

1

Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD) : an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Tye-Din, J. | Daveson, A. | Goel, G. | +49

CommentIn: Lancet Gastroenterol Hepatol. 2023 May;8(5):395-396. - PMID 36898392

2

A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease

enthalten in: Frontiers in immunology | 2021

von Hardy, M. | Goel, G. | Russell, A. | +12

3

Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease

enthalten in: BMC medicine | 2020

von Tye-Din, J. | Daveson, A. | Goldstein, K. | +47

4

Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity

enthalten in: United European gastroenterology journal | 2020

von Tye-Din, J. | Skodje, G. | Sarna, V. | +9

5

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Daveson, A. | Tye-Din, J. | Goel, G. | +48

CommentIn: Aliment Pharmacol Ther. 2020 Feb;51(3):403-404. - PMID 31943270

6

Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Tye-Din, J. | Daveson, A. | Ee, H. | +8

7

Randomised clinical trial : a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Truitt, K. | Daveson, A. | Ee, H. | +4

CommentIn: Aliment Pharmacol Ther. 2019 Oct;50(8):955-956. - PMID 31591769

8

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease

enthalten in: Science advances | 2019

von Goel, G. | Tye-Din, J. | Qiao, S. | +13

1
[1]